1-[3-[2-(4-imidazol-3-id-2-yl-1-methylimidazol-2-yl)propan-2-yl]benzene-2-id-1-yl]oxyimidazo[1,5-a]pyridine;platinum(2+)
C23H20N6OPt — CID 58709106
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-[2-(4-imidazol-3-id-2-yl-1-methylimidazol-2-yl)propan-2-yl]benzene-2-id-1-yl]oxyimidazo[1,5-a]pyridine;platinum(2+)
1-[3-[2-(4-imidazol-3-id-2-yl-1-methylimidazol-2-yl)propan-2-yl]benzene-2-id-1-yl]oxyimidazo[1,5-a]pyridine;platinum(2+) (PubChem CID 58709106) has the molecular formula C23H20N6OPt and a molecular weight of 591.53 g/mol. Its IUPAC name is 1-[3-[2-(4-imidazol-3-id-2-yl-1-methylimidazol-2-yl)propan-2-yl]benzene-2-id-1-yl]oxyimidazo[1,5-a]pyridine;platinum(2+).
Molecular Properties
| Compound Name | 1-[3-[2-(4-imidazol-3-id-2-yl-1-methylimidazol-2-yl)propan-2-yl]benzene-2-id-1-yl]oxyimidazo[1,5-a]pyridine;platinum(2+) |
|---|---|
| PubChem CID | 58709106 |
| Molecular Formula | C23H20N6OPt |
| Molecular Weight | 591.53 g/mol |
| Exact Mass | 591.13 |
| IUPAC Name | 1-[3-[2-(4-imidazol-3-id-2-yl-1-methylimidazol-2-yl)propan-2-yl]benzene-2-id-1-yl]oxyimidazo[1,5-a]pyridine;platinum(2+) |
| SMILES | Cn1cc(-c2ncc[n-]2)nc1C(C)(C)c1[c-]c(Oc2ncn3ccccc23)ccc1.[Pt+2] |
| InChI | InChI=1S/C23H20N6O.Pt/c1-23(2,22-27-18(14-28(22)3)20-24-10-11-25-20)16-7-6-8-17(13-16)30-21-19-9-4-5-12-29(19)15-26-21;/h4-12,14-15H,1-3H3;/q-2;+2 |
| InChIKey | PQPCRCBSKBDFDA-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 71.34 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 591.53 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58709106 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.